- Home
- MIRM vs OZKAP Comparison
MIRM vs OZKAP Comparison
Compare MIRM & OZKAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIRM | OZKAP |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United States |
| Employees | N/A | 3351 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | N/A |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | MIRM | OZKAP |
|---|---|---|
| Price | $100.00 | $15.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $119.85 | N/A |
| AVG Volume (30 Days) | ★ 442.2K | 25.9K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,138,000.00 | N/A |
| Revenue This Year | $26.22 | N/A |
| Revenue Next Year | $22.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $63.23 | $15.50 |
| 52 Week High | $130.00 | $17.85 |
Technical Indicators
Market Signals| Indicator | MIRM | OZKAP |
|---|---|---|
| Relative Strength Index (RSI) | 42.76 | 19.09 |
| Support Level | $97.49 | N/A |
| Resistance Level | $105.20 | $16.57 |
| Average True Range (ATR) | 3.27 | 0.20 |
| MACD | 0.53 | -0.08 |
| Stochastic Oscillator | 45.64 | 8.33 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About OZKAP Bank OZK 4.625% Series A Non-Cumulative Perpetual Preferred Stock
Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides banking services, including checking, savings, money market, time deposits, and individual retirement accounts, as well as loan services, such as real estate, consumer, commercial, and industrial loans. Apart from providing traditional banking products and services, it also provides trust and wealth management, financial planning, online banking, and other related services.